Lantern Pharma Inc. · NASDAQ:LTRN

BIOS ADVISORS GP, LLC reported a 4.48% stake in Lantern Pharma Inc. (Schedule 13D/A)

Event May 15, 2026 · Filed May 15, 2026

BIOS ADVISORS GP, LLC reported a 4.48% stake in Lantern Pharma Inc., 571,305 shares, with active intent on May 15, 2026. Filed May 15, 2026 (Schedule 13D/A).

Stake
4.48%
Shares
571,305
Intent
Active
What changed
Stake changed
Filed together
14 holders

The filing in full

HolderStakeShares
BIOS ADVISORS GP, LLC4.48%571,305
AARON G.L. FLETCHER4.48%571,305
CAVU MANAGEMENT, LP4.48%571,305
CAVU ADVISORS, LLC4.48%571,305
LESLIE W. KREIS4.48%571,305
BIOS EQUITY PARTNERS, LP2.09%266,621
BIOS EQUITY PARTNERS II, LP2.39%304,684
BIOS CAPITAL MANAGEMENT, LP4.48%571,305
BIOS FUND II NT, LP0.22%28,324
BIOS FUND II QP, LP1.66%211,566
BIOS FUND II, LP0.51%64,794
BP DIRECTORS, LP0.20%26,093
BIOS FUND I QP, LP0.70%88,769
Bios Fund I, LP1.19%151,759

Source

View original at SEC

Related